Pardes Biosciences Inc Ordinary Shares PRDS 深 沪
等待开盘 07-30 09:30:00 美东时间
2.16
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 2.16
- 总市值 1.34亿
- 52周最高 3.67
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.75
- 委 比 0.00%
- 总股本 6201.18万
- 历史最高 17.76
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.75
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jasper Therapeutics Announces Appointment Of Thomas G. Wiggans As Chairperson Of The Board Of Directors
Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic
2023-11-01 20:17
Moore Kuehn Encourages PRDS, AMNB, NLTX, and SCU Investors to Contact Law Firm
NEW YORK, Aug. 3, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims con...
2023-08-04 03:15
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
Upgrades For Carnival Corp (NYSE:CCL), Argus Research upgraded the previous rat...
2023-07-18 23:00
Pardes Biosciences Analyst Ratings
What is the target price for Pardes Biosciences (PRDS)? The latest price tar...
2023-07-18 17:22
JMP Securities Downgrades Pardes Biosciences to Market Perform
JMP Securities analyst Roy Buchanan downgrades Pardes Biosciences (NASDAQ:PRDS) from Market Outperform to Market Perform.
2023-07-18 17:22
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, KDNY, AEL
NEW YORK, July 17, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2023-07-18 05:28
Why Pardes Biosciences Shares Are Rising Monday
Pardes Biosciences Inc (NASDAQ: PRDS) shares are trading higher Monday after MediPacific agreed to acquire the company.
2023-07-17 21:25
Recap: Pardes Biosciences Q1 Earnings
Pardes Biosciences (NASDAQ:PRDS) reported its Q1 earnings results on Friday, Ma...
2023-05-06 04:05
Pardes Biosciences Q1 EPS $(0.30) Beats $(0.41) Estimate
Pardes Biosciences (NASDAQ:PRDS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.41) by 26.83 percent. This is a 21.05 percent increase over losses of $(0.38) per share
2023-05-06 04:01
Comparing Pardes Biosciences (PRDS) and Its Competitors
Pardes Biosciences (NASDAQ:PRDS – Get Rating) is one of 993 public companies in...
2023-04-22 17:23
